We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.055 | 2.72% | 2.075 | 2.00 | 2.15 | 2.07 | 1.91 | 2.07 | 1,046,404 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.76 | 6.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/12/2017 12:11 | Sorry if this annoys you fundamentalists out there, but all that has happened this morning is a back test of the last breakout (take a good look at the candle chart - it is perfect). If we pull away from here then this is a very strong sign that the bullish run will continue - all bar something completely out of left field. The chart will look excellent. | lord gnome | |
20/12/2017 12:08 | Wow, look at the volume for time of day. Grisly bear tree shake, maybe full now. | bolador | |
20/12/2017 11:53 | adorling20 Dec '17 - 10:56 - 7745 of 7753 Just added 9900 and 10100 shares at 146p... 9900 just through so multiple delays in reporting trades...buy/sell ratios out of the window | sportbilly1976 | |
20/12/2017 11:41 | todger60mm's deramping is getting more desperate by the minute. | luminoso | |
20/12/2017 11:41 | Come on MoneyMaker1. Time for another one of your pie in the sky posts with numbers. | divmad | |
20/12/2017 11:29 | badger60 Get your FACTS RIGHT....Funded through to end of 2018+ You are TRYING TO MISLEAD people! | flavio_monteiro | |
20/12/2017 11:10 | more than 70 k available under 170 in my l2 | jpleight | |
20/12/2017 11:09 | MM's must have got a large buy order so collected peoples stop losses to fill it, we usually get a couple of days sharp rises after these kind of games | spmc | |
20/12/2017 11:02 | Just added too 6000 at 146p. Strong volume on this bounce 880,000 shares traded so far today | legg96 | |
20/12/2017 10:56 | Just added 9900 and 10100 shares at 146p... | adorling | |
20/12/2017 10:56 | Buy those dips Sir, remember the pull back to 83p, some do they are still sobbing for being mugged | ny boy | |
20/12/2017 10:53 | 72,500 at 144.5p - no way a real-time sell trade | sportbilly1976 | |
20/12/2017 10:51 | Just hit the Filter option: spmc 20 Dec '17 - 10:40 - 7741 of 7741 (Filtered) | gbh2 | |
20/12/2017 10:40 | How do you filter people? Need to filter badger60 not sure if I can bare to read any more of his tripe | spmc | |
20/12/2017 10:38 | Badger There is some hype that`s true but much more solid views based on what is known so far. You only offer pessimistic prose full of sound and fury signifying nothing. I shall now filter you as your contributions are worthless. | arcadian | |
20/12/2017 10:36 | Been advised by the company they will definately issue another Update when the last patient has received their last dose in the current Phase 3 Lupuzor trial, but they cannot privately disclose the day in advance on an individual shareholder basis. Also confirmed that once the last patient commenced dosing earlier this year (Update, 25/1/2017) the timetable for their dosings and evaluations was fixed (in accordance with the trial design) and will not alter; so it becomes quite straightforward to predict the last patient evaluation is in January, with the last dose 28 days beforehand. | hottingup | |
20/12/2017 10:34 | badger are you stupid buy the dip WJ. | w1ndjammer | |
20/12/2017 10:33 | Certainly Santa delivered early this morning! | ny boy | |
20/12/2017 10:25 | Missing out on all the £bns of hype her and £bns of hype there... Come on chaps rally the troops . Mouthwatering revenues just around the corner......fill yer boots!!!!!! | badger60 | |
20/12/2017 10:21 | Been advised by the company they will definately issue another Update when the last patient has received their last dose in the current Phase 3 Lupuzor trial, but they cannot privately disclose the day in advance on an individual shareholder basis. Also confirmed that once the last patient commenced dosing earlier this year (Update, 25/1/2017) the timetable for their dosings and evaluations was fixed (in accordance with the trial design) and will not alter; so it becomes quite straightforward to predict the last patient evaluation is in January, with the last dose 28 days beforehand. | hottingup | |
20/12/2017 10:18 | Looking at the trades yesterday, the trades and volume did not justify the move down from the 160s to the 150s and I can only conclude that the MMs are simply trying to encourage weak holders to sell so that they have the stock to sell when the results are published. If the results are as expected there will be value and potential but we will then see efforts to ensure that we are not the main beneficiaries. Only a full bidding war could achieve this but there will be devices devised to obviate this. The attitude BOD and the deals they are offered will determine whether present investors get a fair deal. Don`t hold your breath. It`s happening now. They are trying to make money out of it too and they are more experienced and better placed than us. | arcadian | |
20/12/2017 10:08 | Only 20,000 share available sub £1.70 big bounce coming... | spmc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions